UTHR · US market

UNITED THERAPEUTICS

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$24.51bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E18.69×
Latest-quarter run-rate P/E18.40×
Trailing P/S7.77×
Latest-quarter run-rate P/S7.82×

Calculation inputs

Trailing earnings
US$1.31bn
Latest-quarter run-rate earnings
US$1.33bn
Latest fiscal-year earnings
US$1.33bn
Trailing revenue
US$3.15bn
Latest-quarter run-rate revenue
US$3.13bn
Latest fiscal-year revenue
US$3.18bn

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • LOGSX · Live Oak Health Sciences Fund6.40% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • IBBQ · Invesco Nasdaq Biotechnology ETF6.28% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PBE · Invesco Biotechnology & Genome ETF6.28% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PFPFX · Poplar Forest Partners Fund Class A4.85% weight · Holdings dated 30 June 2026
  • XMHQ · Invesco S&P MidCap Quality ETF3.98% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PJP · Invesco Pharmaceuticals ETF3.54% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • HELX · Franklin Genomic Advancements ETF3.51% weight · Holdings dated 30 June 2026
  • MCGAX · Transamerica Mid Cap Growth A2.92% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • BBH · VanEck Biotech ETF2.83% weight · Holdings dated 30 June 2026
  • FTXH · First Trust Nasdaq Pharmaceuticals ETF2.72% weight · Holdings dated 30 June 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.